Perioperative chemotherapy with mFOLFOX6 or CAPOX for patients with locally advanced colon cancer (OPTICAL): A multicenter, randomized, phase 3 trial.

被引：0
|
作者：
Hu, Huabin
Huang, Meijin
Li, Yunfeng
Wang, Ziqiang
Wang, Xiaozhong
Liu, Ping
Zhang, Ruyi
Zhang, Hao
Huang, Zhongcheng
Pei, Haiping
Zeng, Yongming
Lai, Jiajun
Chen, Wenbin
Chen, Jiansi
Ding, Zhijie
Wei, Hongbo
Xu, Qingwen
Chen, Jigui
Wang, Jianping
Deng, Yanhong
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3500
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Consolidation mFOLFOX6 Chemotherapy After Chemoradiotherapy Improves Survival in Patients With Locally Advanced Rectal Cancer: Final Results of a Multicenter Phase II Trial
    Marco, Michael R.
    Zhou, Lihong
    Patil, Sujata
    Marcet, Jorge E.
    Varma, Madhulika G.
    Oommen, Samuel
    Cataldo, Peter A.
    Hunt, Steven R.
    Kumar, Anjali
    Herzig, Daniel O.
    Fichera, Alessandro
    Polite, Blase N.
    Hyman, Neil H.
    Ternent, Charles A.
    Stamos, Michael J.
    Pigazzi, Alessio
    Dietz, David
    Yakunina, Yuliya
    Pelossof, Raphael
    Garcia-Aguilar, Julio
    DISEASES OF THE COLON & RECTUM, 2018, 61 (10) : 1146 - 1155
  • [2] Long-term outcome of neoadjuvant mFOLFOX6 with or without radiation versus fluorouracil plus radiation for locally advanced rectal cancer: A multicenter, randomized phase III trial.
    Zhang, Jianwei
    Chi, Pan
    Lan, Ping
    Cui, Long
    Wei, Hongbo
    Zhao, Ren
    Huang, Zhongcheng
    Zhang, Hao
    Cai, Yue
    Wang, Jianping
    Deng, Yanhong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] XELOX or mFOLFOX6 chemotherapy combined with resection of primary lesion versus chemotherapy alone for colon cancer with unresectable metastases: A randomized clinical trial.
    Guo, Weijian
    Li, Xinxiang
    Huang, Mingzhu
    Yang, Ya'nan
    Li, Qingguo
    Wang, Chenchen
    Liang, Lei
    Zhu, Xiaodong
    Zhang, Wen
    Chen, Zhiyu
    Li, Wenhua
    Zhang, Xiaowei
    Zhao, Xiaoying
    Qiu, Lixin
    Geng, Qirong
    Sheng, Xuedan
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] Comparisons of effects of SOX and mFOLFOX6 chemotherapy regimens on patients with locally advanced gastric cancer
    Chen, Gui-Dong
    Cao, Bin-Xiao
    Shi, Ying
    Lv, Jie-Min
    Wang, Dong-Hai
    Shi, Lun-Bo
    JOURNAL OF CHEMOTHERAPY, 2022, 34 (02) : 117 - 122
  • [5] Randomized Controlled Trial of Intraportal Chemotherapy Combined With Adjuvant Chemotherapy (mFOLFOX6) for Stage II and III Colon Cancer
    Chang, Wenju
    Wei, Ye
    Ren, Li
    Zhong, Yunshi
    Yu, Yiyi
    Chen, Jingwen
    Zhu, Dexiang
    Ye, Lechi
    Qin, Chunzhi
    Zhao, Naiqing
    Niu, Weixin
    Qin, Xinyu
    Xu, Jianmin
    ANNALS OF SURGERY, 2016, 263 (03) : 434 - 439
  • [6] A randomized phase II study comparing preoperative mFOLFOX6 versus FOLFOXIRI for locally advanced colon cancer: JCOG2006
    Hashimoto, Tadayoshi
    Maruyama, Satoshi
    Takii, Yasumasa
    Mizusawa, Junki
    Kataoka, Tomoko
    Fukuda, Haruhiko
    Tsukamoto, Shunsuke
    Takashima, Atsuo
    Hamaguchi, Tetsuya
    Kanemitsu, Yukihide
    Colorectal Canc Study Grp, Colorectal Canc Study Grp
    Japan Clinical Oncology Grp, Japan Clinical Oncology Grp
    FUTURE ONCOLOGY, 2023, 19 (28) : 1897 - 1904
  • [7] CapOX as neoadjuvant chemotherapy for locally advanced operable colon cancer patients: a prospective single-arm phase Ⅱ trial
    Fangqi Liu
    Li Yang
    Yuchen Wu
    Cong Li
    Jiang Zhao
    Adili Keranmu
    Hongtu Zheng
    Dan Huang
    Lei Wang
    Tong Tong
    Junyan Xu
    Ji Zhu
    Sanjun Cai
    Ye Xu
    Chinese Journal of Cancer Research, 2016, 28 (06) : 589 - 597
  • [8] Randomized Controlled Trial of the Intraportal Chemotherapy Combined With Adjuvant Chemotherapy (mFOLFOX6) for Stage II and III Colon Cancer
    Gogenur, Mikail
    Gogenur, Ismail
    ANNALS OF SURGERY, 2017, 266 (06) : E105 - E106
  • [9] A Japanese multicenter phase II study of adjuvant chemotherapy with mFOLFOX6/CAPOX for stage III colon cancer treatment after D2/D3 lymphadenectomy
    Kazuhiko Yoshimatsu
    Keiichiro Ishibashi
    Keiji Koda
    Hajime Yokomizo
    Noritaka Oda
    Mitsuru Oshiro
    Hiroyuki Kato
    Masatoshi Oya
    Hideo Nakajima
    Shinji Ooki
    Hiroshi Maekawa
    Toshio Matsunami
    Masahiro Tsubaki
    Takeshi Yamada
    Michiya Kobayashi
    Kohji Tanakaya
    Masaru Yokoyama
    Hideyuki Ishida
    Surgery Today, 2019, 49 : 498 - 506
  • [10] A Japanese multicenter phase II study of adjuvant chemotherapy with mFOLFOX6/CAPOX for stage III colon cancer treatment after D2/D3 lymphadenectomy
    Yoshimatsu, Kazuhiko
    Ishibashi, Keiichiro
    Koda, Keiji
    Yokomizo, Hajime
    Oda, Noritaka
    Oshiro, Mitsuru
    Kato, Hiroyuki
    Oya, Masatoshi
    Nakajima, Hideo
    Ooki, Shinji
    Maekawa, Hiroshi
    Matsunami, Toshio
    Tsubaki, Masahiro
    Yamada, Takeshi
    Kobayashi, Michiya
    Tanakaya, Kohji
    Yokoyama, Masaru
    Ishida, Hideyuki
    SURGERY TODAY, 2019, 49 (06) : 498 - 506
12345